3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Craniopharyngioma
1
Choroid Plexus Neoplasms
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Radiotherapy, Image-Guided
×
Clear all
No trials found.